SLC25A38 as a novel biomarker for metastasis and clinical outcome in uveal melanoma.

导出 OA

翻译打印收藏纠错

第一作者： Zhongyi,Fan

第一单位： Department of Oncology and Bio-therapeutic Center, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen Research Center for Communicable Disease Diagnosis and Treatment, Shenzhen, 518112, China.

作者： Zhongyi,Fan ^[1] ; Jingjing,Duan ^[2] ; Pu,Luo ^[3] ; Ling,Shao ^[1] ; Qiong,Chen ^[1] ; Xiaohua,Tan ^[1] ; Lei,Zhang ^[4] ; Xiaojie,Xu ^[5]

作者单位： Department of Oncology and Bio-therapeutic Center, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen Research Center for Communicable Disease Diagnosis and Treatment, Shenzhen, 518112, China. ^[1] Department of Oncology, The First Medical Center, General Hospital of PLA, Beijing, 100853, China. ^[2] Department of Gastrointestinal Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. ^[3] Department of Oncology and Bio-therapeutic Center, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen Research Center for Communicable Disease Diagnosis and Treatment, Shenzhen, 518112, China. xiaohua_t@126.com. ^[4] Department of Ophthalmology, Xuanwu Hospital Attached to the Capital Medical University, Beijing, 100053, China. zhangleixwyy@sina.com. ^[5] Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, 100850, China. miraclexxj@126.com. ^[6]